Traders should not interpret this Form 144 as a negative signal; it reflects a standard tax settlement mechanism following RSU vesting, not a voluntary sale. Monitor for any additional discretionary Form 14s or Form 4s for signs of actual insider sentiment.
Price Chart
Executive Summary
Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to report a mandatory 'sell to cover' transaction of 37,500 shares to satisfy tax withholding obligations following the vesting of performance-based restricted stock units. This is not a discretionary sale.
Key Facts
- Elizabeth E. Reed, an officer, is reporting a proposed sale of 37,500 common shares.
- The sale is a mandatory 'sell to cover' transaction to fund tax withholding obligations from vested performance restricted stock units.
- The transaction occurred on April 14, 2026, and was not a discretionary trade by the insider.
- Total value of the sale was approximately $1.54 million based on a share price of ~$41.07.
- This follows a pattern of similar non-discretionary sales by the same insider over the past few months.
Financial Impact
Approximately $1.54 million in shares to be sold, representing tax-related obligations rather than insider divestment.
Risk Factors
- Potential misinterpretation by retail investors as a discretionary insider sale, leading to unwarranted selling pressure.
- Continued pattern of tax-related sales could signal upcoming vesting events that may periodically increase share supply.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001193125-26-155628 |
| Document: 0001193125-26-155628-index.html | 0001193125-26-155628 |
| Document: 0001193125-26-155628.txt | 0001193125-26-155628 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 12w ago | 8-K | $56.59 $61.32 | ▲ +8.36% | ▲ +5.93% | $56.93 (+0.60%) |
Jun 16, 2026 15w ago | Insider Cluster | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 16, 2026 15w ago | 8-K | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 12, 2026 16w ago | 144 | $52.04 $56.59 | ▲ +8.74% | ▲ +6.96% | $56.93 (+9.40%) |
Jun 2, 2026 17w ago | 8-K | $42.96 $56.34 | ▲ +31.15% | ▲ +32.71% | $56.93 (+32.52%) |
May 15, 2026 20w ago | 144 | $42.59 $53.80 | ▲ +26.32% | ▲ +24.20% | $56.93 (+33.67%) |
May 5, 2026 21w ago | 144 | $44.76 $45.20 | ▲ +0.98% | ▼ −1.80% | $56.93 (+27.19%) |
May 4, 2026 21w ago | 144 | $44.80 $42.96 | ▼ −4.11% | ▼ −9.06% | $56.93 (+27.08%) |
May 1, 2026 22w ago | Insider Cluster | $44.12 $45.04 | ▼ −2.09% | ▲ +3.20% | $56.93 (−29.03%) |
Apr 15, 2026 24w ago | 144 | $40.95 $42.84 | ▲ +4.62% | ▼ −1.43% | $56.93 (+39.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access